Cite
MLA Citation
Robert Jones et al.. “A randomised Phase II trial of carboplatin and gemcitabine ± vandetanib in first‐line treatment of patients with advanced urothelial cell cancer not suitable to receive cisplatin.” BJU international, vol. 126, 2020, pp. 292–299. http://access.bl.uk/ark:/81055/vdc_100106113375.0x000032